Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice

Poxvirus-based active immunotherapies mediate anti-tumor efficacy by triggering broad and durable Th1 dominated T cell responses against the tumor. While monotherapy significantly delays tumor growth, it often does not lead to complete tumor regression. It was hypothesized that the induced robust in...

Descripción completa

Detalles Bibliográficos
Autores principales: Foy, Susan P., Sennino, Barbara, dela Cruz, Tracy, Cote, Joseph J., Gordon, Evan J., Kemp, Felicia, Xavier, Veronica, Franzusoff, Alex, Rountree, Ryan B., Mandl, Stefanie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765931/
https://www.ncbi.nlm.nih.gov/pubmed/26910562
http://dx.doi.org/10.1371/journal.pone.0150084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765931/
https://www.ncbi.nlm.nih.gov/pubmed/26910562
http://dx.doi.org/10.1371/journal.pone.0150084

Ejemplares similares